Li M - Search Results

1

Focusing on non-responders to infliximab with ulcerative colitis, what can we do first and next?

Pu D, Wang P, Wang X, Tian Y, Gong H, Ma X, Li M, Zhang D. Pu D, et al. Among authors: li m. Int Immunopharmacol. 2024 Nov 15;141:112943. doi: 10.1016/j.intimp.2024.112943. Epub 2024 Aug 24. Int Immunopharmacol. 2024. PMID: 39191122

2

Dihydromyricetin ameliorates experimental ulcerative colitis by inhibiting neutrophil extracellular traps formation via the HIF-1α/VEGFA signaling pathway.

Ma X, Li M, Wang X, Xu H, Jiang L, Wu F, Wei L, Qi G, Zhang D. Ma X, et al. Among authors: li m. Int Immunopharmacol. 2024 Sep 10;138:112572. doi: 10.1016/j.intimp.2024.112572. Epub 2024 Jul 1. Int Immunopharmacol. 2024. PMID: 38955027

3

Nets in fibrosis: Bridging innate immunity and tissue remodeling.

Ma X, Li J, Li M, Qi G, Wei L, Zhang D. Ma X, et al. Among authors: li j, li m. Int Immunopharmacol. 2024 Aug 20;137:112516. doi: 10.1016/j.intimp.2024.112516. Epub 2024 Jun 19. Int Immunopharmacol. 2024. PMID: 38906006 Review.

4

Molecular mechanism and therapeutic significance of dihydromyricetin in nonalcoholic fatty liver disease.

Gong H, Xu H, Li M, Zhang D. Gong H, et al. Among authors: li m. Eur J Pharmacol. 2022 Nov 15;935:175325. doi: 10.1016/j.ejphar.2022.175325. Epub 2022 Oct 17. Eur J Pharmacol. 2022. PMID: 36265611 Review.

5

SUMOylation at the crossroads of gut health: insights into physiology and pathology.

Ma XN, Li MY, Qi GQ, Wei LN, Zhang DK. Ma XN, et al. Cell Commun Signal. 2024 Aug 19;22(1):404. doi: 10.1186/s12964-024-01786-5. Cell Commun Signal. 2024. PMID: 39160548 Free PMC article. Review.

6

Sialylation in the gut: From mucosal protection to disease pathogenesis.

Ma X, Li M, Wang X, Qi G, Wei L, Zhang D. Ma X, et al. Among authors: li m. Carbohydr Polym. 2024 Nov 1;343:122471. doi: 10.1016/j.carbpol.2024.122471. Epub 2024 Jul 9. Carbohydr Polym. 2024. PMID: 39174097 Review.

7

Assessment of the quality, diagnosis, and therapeutic recommendations of clinical practice guidelines on patients with Helicobacter pylori infection: A systematic review.

Li M, Ma X, Xu H, Han M, Gou L, Du H, Wei L, Zhang D. Li M, et al. Gastroenterol Hepatol. 2024 Jun-Jul;47(6):627-645. doi: 10.1016/j.gastrohep.2024.01.006. Epub 2024 Feb 1. Gastroenterol Hepatol. 2024. PMID: 38307489 Review. English, Spanish.

8

Evidence Mapping of Proton Therapy, Heavy Ion Therapy, and Helical Tomotherapy for Gastric Cancer.

Li M, Dou W, Lin Y, Li Q, Xu H, Zhang D. Li M, et al. Among authors: li q. Oncol Res Treat. 2021;44(12):700-709. doi: 10.1159/000518997. Epub 2021 Oct 25. Oncol Res Treat. 2021. PMID: 34695829

9

Using Mendelian randomization as the cornerstone for causal inference in epidemiology.

Xu J, Li M, Gao Y, Liu M, Shi S, Shi J, Yang K, Zhou Z, Tian J. Xu J, et al. Among authors: li m. Environ Sci Pollut Res Int. 2022 Jan;29(4):5827-5839. doi: 10.1007/s11356-021-15939-3. Epub 2021 Aug 24. Environ Sci Pollut Res Int. 2022. PMID: 34431050

10

Comparison of different transcatheter interventions for treatment of mitral regurgitation: A protocol for a network meta-analysis.

Zhang B, Li M, Kang Y, Xing L, Zhang Y. Zhang B, et al. Among authors: li m. Medicine (Baltimore). 2020 Dec 11;99(50):e23623. doi: 10.1097/MD.0000000000023623. Medicine (Baltimore). 2020. PMID: 33327338 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75,820 results

Search Page

Filters